1-16988207-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_022089.4(ATP13A2):​c.2790G>A​(p.Ser930Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.208 in 1,613,830 control chromosomes in the GnomAD database, including 39,054 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.21 ( 4003 hom., cov: 33)
Exomes 𝑓: 0.21 ( 35051 hom. )

Consequence

ATP13A2
NM_022089.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:13

Conservation

PhyloP100: -2.31

Publications

38 publications found
Variant links:
Genes affected
ATP13A2 (HGNC:30213): (ATPase cation transporting 13A2) This gene encodes a member of the P5 subfamily of ATPases which transports inorganic cations as well as other substrates. Mutations in this gene are associated with Kufor-Rakeb syndrome (KRS), also referred to as Parkinson disease 9. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Nov 2008]
ATP13A2 Gene-Disease associations (from GenCC):
  • Kufor-Rakeb syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Illumina, Genomics England PanelApp, G2P, ClinGen
  • autosomal recessive spastic paraplegia type 78
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae)
  • parkinsonism due to ATP13A2 deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.61).
BP6
Variant 1-16988207-C-T is Benign according to our data. Variant chr1-16988207-C-T is described in ClinVar as Benign. ClinVar VariationId is 128468.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.31 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.544 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ATP13A2NM_022089.4 linkc.2790G>A p.Ser930Ser synonymous_variant Exon 25 of 29 ENST00000326735.13 NP_071372.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ATP13A2ENST00000326735.13 linkc.2790G>A p.Ser930Ser synonymous_variant Exon 25 of 29 1 NM_022089.4 ENSP00000327214.8

Frequencies

GnomAD3 genomes
AF:
0.212
AC:
32184
AN:
152022
Hom.:
3993
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.147
Gnomad AMI
AF:
0.161
Gnomad AMR
AF:
0.305
Gnomad ASJ
AF:
0.186
Gnomad EAS
AF:
0.560
Gnomad SAS
AF:
0.239
Gnomad FIN
AF:
0.311
Gnomad MID
AF:
0.231
Gnomad NFE
AF:
0.188
Gnomad OTH
AF:
0.228
GnomAD2 exomes
AF:
0.249
AC:
62714
AN:
251422
AF XY:
0.245
show subpopulations
Gnomad AFR exome
AF:
0.152
Gnomad AMR exome
AF:
0.334
Gnomad ASJ exome
AF:
0.179
Gnomad EAS exome
AF:
0.551
Gnomad FIN exome
AF:
0.301
Gnomad NFE exome
AF:
0.193
Gnomad OTH exome
AF:
0.239
GnomAD4 exome
AF:
0.208
AC:
304210
AN:
1461690
Hom.:
35051
Cov.:
36
AF XY:
0.208
AC XY:
151555
AN XY:
727150
show subpopulations
African (AFR)
AF:
0.148
AC:
4939
AN:
33476
American (AMR)
AF:
0.330
AC:
14739
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.176
AC:
4603
AN:
26136
East Asian (EAS)
AF:
0.534
AC:
21186
AN:
39698
South Asian (SAS)
AF:
0.227
AC:
19549
AN:
86256
European-Finnish (FIN)
AF:
0.293
AC:
15641
AN:
53408
Middle Eastern (MID)
AF:
0.208
AC:
1199
AN:
5768
European-Non Finnish (NFE)
AF:
0.188
AC:
209077
AN:
1111848
Other (OTH)
AF:
0.220
AC:
13277
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
15574
31148
46723
62297
77871
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
7522
15044
22566
30088
37610
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.212
AC:
32216
AN:
152140
Hom.:
4003
Cov.:
33
AF XY:
0.222
AC XY:
16509
AN XY:
74362
show subpopulations
African (AFR)
AF:
0.148
AC:
6128
AN:
41520
American (AMR)
AF:
0.305
AC:
4669
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.186
AC:
645
AN:
3470
East Asian (EAS)
AF:
0.561
AC:
2888
AN:
5152
South Asian (SAS)
AF:
0.239
AC:
1155
AN:
4826
European-Finnish (FIN)
AF:
0.311
AC:
3282
AN:
10564
Middle Eastern (MID)
AF:
0.228
AC:
67
AN:
294
European-Non Finnish (NFE)
AF:
0.188
AC:
12754
AN:
67992
Other (OTH)
AF:
0.228
AC:
481
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1277
2554
3830
5107
6384
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
342
684
1026
1368
1710
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.196
Hom.:
6125
Bravo
AF:
0.211
Asia WGS
AF:
0.358
AC:
1242
AN:
3478
EpiCase
AF:
0.197
EpiControl
AF:
0.200

ClinVar

Significance: Benign
Submissions summary: Benign:13
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
Aug 15, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 15, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 40% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 37. Only high quality variants are reported. -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Oct 22, 2015
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jul 05, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Kufor-Rakeb syndrome Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Kufor-Rakeb syndrome;C5567893:Autosomal recessive spastic paraplegia type 78 Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Feb 24, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.61
CADD
Benign
0.85
DANN
Benign
0.89
PhyloP100
-2.3
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3738815; hg19: chr1-17314702; COSMIC: COSV58700021; COSMIC: COSV58700021; API